APA (7th ed.) Citation

D, A. L., A, A., M, A., M, O., B, M., Q, A., . . . N, A. (2024). BRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited country. Frontiers in oncology, 14, 1417484. https://doi.org/10.3389/fonc.2024.1417484

Chicago Style (17th ed.) Citation

D, Abu Laban, et al. "BRAF/MEK Inhibitors Use for Pediatric Gliomas; Real World Experience from a Resource-limited Country." Frontiers in Oncology 14 (2024): 1417484. https://doi.org/10.3389/fonc.2024.1417484.

MLA (9th ed.) Citation

D, Abu Laban, et al. "BRAF/MEK Inhibitors Use for Pediatric Gliomas; Real World Experience from a Resource-limited Country." Frontiers in Oncology, vol. 14, 2024, p. 1417484, https://doi.org/10.3389/fonc.2024.1417484.